GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Beijing Chunlizhengda Medical Instruments Co Ltd (HKSE:01858) » Definitions » Accounts Receivable

Beijing Chunlizhengda Medical Instruments Co (HKSE:01858) Accounts Receivable : HK$444.0 Mil (As of Dec. 2023)


View and export this data going back to 2015. Start your Free Trial

What is Beijing Chunlizhengda Medical Instruments Co Accounts Receivable?

Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Beijing Chunlizhengda Medical Instruments Co's accounts receivables for the quarter that ended in Dec. 2023 was HK$444.0 Mil.

Accounts receivable can be measured by Days Sales Outstanding. Beijing Chunlizhengda Medical Instruments Co's Days Sales Outstanding for the quarter that ended in Dec. 2023 was 88.95.

In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. Beijing Chunlizhengda Medical Instruments Co's Net-Net Working Capital per share for the quarter that ended in Dec. 2023 was HK$5.27.


Beijing Chunlizhengda Medical Instruments Co Accounts Receivable Historical Data

The historical data trend for Beijing Chunlizhengda Medical Instruments Co's Accounts Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing Chunlizhengda Medical Instruments Co Accounts Receivable Chart

Beijing Chunlizhengda Medical Instruments Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Accounts Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 179.87 262.32 490.02 545.79 443.96

Beijing Chunlizhengda Medical Instruments Co Quarterly Data
Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Sep22 Dec22 Jun23 Sep23 Dec23 Mar24
Accounts Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 545.79 633.22 571.69 443.96 -

Beijing Chunlizhengda Medical Instruments Co Accounts Receivable Calculation

Accounts Receivable is money owed to a business by customers and shown on its Balance Sheet as an asset.


Beijing Chunlizhengda Medical Instruments Co Accounts Receivable Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.

Beijing Chunlizhengda Medical Instruments Co's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=443.96/455.415*91
=88.95

2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), Beijing Chunlizhengda Medical Instruments Co's accounts receivable are only considered to be worth 75% of book value:

Beijing Chunlizhengda Medical Instruments Co's Net-Net Working Capital Per Share for the quarter that ended in Dec. 2023 is calculated as:

Net-Net Working Capital Per Share
=(Cash And Cash Equivalents+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(2295.171+0.75 * 443.96+0.5 * 475.232-842.565
-0-1.935)/383.569
=5.27

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.

If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.

Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.


Beijing Chunlizhengda Medical Instruments Co Accounts Receivable Related Terms

Thank you for viewing the detailed overview of Beijing Chunlizhengda Medical Instruments Co's Accounts Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Beijing Chunlizhengda Medical Instruments Co (HKSE:01858) Business Description

Traded in Other Exchanges
Address
No. 10 Xinmi Xi Er Road, Southern District of Tongzhou, Economic Development Zone, Tongzhou District, Beijing, CHN
Beijing Chunlizhengda Medical Instruments Co Ltd is an orthopedic medical device company. It is engaged in the research, development, manufacture, and sale of orthopedic medical devices, including joint prosthesis products and spinal products. The products offered by the company are classified into three categories, namely Standard joint prosthesis products, Custom joint prosthesis products, and Spinal products. It operates in the business segment of manufacture and trading of surgical implants, instruments and related products.
Executives
Fil Limited 2201 Interest of corporation controlled by you
Pandanus Associates Inc. 2201 Interest of corporation controlled by you
Pandanus Partners L.p. 2201 Interest of corporation controlled by you
Brown Brothers Harriman & Co. 2502 Approved lending agent
Citigroup Inc. 2502 Approved lending agent
Fidelity China Special Situations Plc 2101 Beneficial owner
Taiping Assets Management (hk) Company Limited 2102 Investment manager
Taiping Trustees Limited 2301 Trustee

Beijing Chunlizhengda Medical Instruments Co (HKSE:01858) Headlines

No Headlines